Natco files for patent waiver for arthritis drug to fight Covid-19 in Hyderabad

Natco files for patent waiver for arthritis drug to fight Covid-19 in Hyderabad In its application, Natco has cited the unmet medical needs due to the lack of supply and affordability in light of the grave and life-threatening national public health emergency, due to the Covid-19 second wave, as the main grounds for seeking the CL. https://ift.tt/eA8V8J